BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Wednesday, February 11, 2026
Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 2, 2009

View Archived Issues

Letrozole monotherapy better than sequential treatment with tamoxifen in breast cancer patients

Read More

Celladon and Momentum Research complete enrollment in phase II study of Mydicar

Read More

Mitsubishi Tanabe Pharma reports results from second quarter 2009

Read More

FDA grants orphan drug designation to Delcath Systems' doxorubicin in HCC

Read More

Advanced Life Sciences reports results from nonhuman primate study of Restanza in anthrax

Read More

TransPharma Medical completes phase II ViaDerm-hPTH(1-34) trial in osteoporosis

Read More

Icagen reports topline results of phase IIa senicapoc study in allergic asthma

Read More

Catalyst Pharmaceutical Partners licenses rights to new GABA aminotransferase inhibitors

Read More

Cimzia approved for moderate to severe rheumatoid arthritis in Canada

Read More

Amgen claims chemokine CXCR3 receptor antagonists for asthma and other disorders

Read More

ACAT-2 inhibitors for the treatment of lipoprotein disorders disclosed by Kitasato Institute

Read More

Medivir selects cathepsin K inhibitor MIV-711 for development in bone diseases

Read More

Novavax reports results from phase II trial of trivalent VLP seasonal influenza vaccine

Read More

Lilly describes kappa opioid receptor antagonists for the treatment of ethanol use disorders

Read More

Adding colesevelam to a statin and ezetimibe lowers LDL-cholesterol in familial hypercholesterolemia

Read More

Novel prodrugs of antifungal agents in early development at Eisai

Read More

Vernalis presents Chk1 inhibitors for the treatment of cancer and other conditions

Read More

Novel DNA-damaging platinum complexes designed by Universitat de Barcelona

Read More

TRITON-TIMI 38 substudy suggests PPIs are safe with clopidogrel and prasugrel in ACS patients

Read More

Bristol-Myers Squibb acquires Medarex

Read More

First clinical results for BAY-60-4552 in biventricular heart failure reported

Read More

FDA requests additional clinical data from SkyePharma for Flutiform NDA in asthma

Read More

ON-TIME II analysis shows benefit of tirofiban in diabetic STEMI patients

Read More

Initiation of phase II clinical trial of ALX-0081 in patients undergoing PCI

Read More

Sinovac Biotech's H1N1 vaccine approved in SFDA expert meeting

Read More

Geron presents data to FDA in relation to clinical hold on IND for GRNOPC-1

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Feb. 10, 2025.
  • Brain illustration

    MJFF grant supports Bexorg’s translational biomarker work

    BioWorld Science
    Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
  • Illustration of SCAN in Parkinson’s vs healthy subcortex

    SCAN is core circuit affected in Parkinson’s disease

    BioWorld Science
    Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
  • Woman and 3D brain

    Astellas’ ASP-2246 shows promise in stroke management

    BioWorld Science
    Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for Feb. 10, 2026
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing